National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
40Application of the CTG Special Arrangement—original special arrangement supply of a dose of a chemotherapy drug
Start here
Get a plain-English read of 40
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
40 Application of the CTG Special Arrangement—original special arrangement supply of a dose of a chemotherapy drug
(1) This section applies to an original special arrangement supply (the relevant supply) of a dose of a chemotherapy drug under this instrument if the relevant supply is made: (a) to an eligible patient who is a CTG registered patient; and (b) by an approved pharmacist, an approved medical practitioner or an approved hospital authority who is a CTG supplier. (2) Despite paragraphs 27(1)(a) and 28(3)(a) and subsections 36(2), 37(2) and 39(2) of this instrument, subsections 11(1), (2), (3) and (4) (co‑payment reduction etc.) and section 13 (payment by Commonwealth) of the CTG Special Arrangement apply in relation to the relevant supply under this instrument with the modification set out in subsection (3) of this section. (3) A reference in the CTG Special Arrangement to a supply of a pharmaceutical benefit under the CTG Special Arrangement is taken to be a reference to the relevant supply under this instrument. (4) However, the notes to subsections 11(2) and (3) of the CTG Special Arrangement do not apply in relation to the relevant supply under this instrument.
Note: The notes to subsections 11(2) and (3) of the CTG Special Arrangement relate to CTG suppliers making claims for payment under the CTG Special Arrangement. Claims for payment in relation to the relevant supply under this instrument are instead dealt with under section 26 of this instrument.